Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CBUS

Cibus Inc

Jul 26 • 04:00PM ET

9.85

Dollar change -0.12
Percentage change -1.20	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWC VTWV RSSL URTY VTHR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-18.35	Insider Own	32.80%	Shs Outstand	21.24M	Perf Week	4.79%
Market Cap	224.97M	Forward P/E	-	EPS next Y	-2.40	Insider Trans	-0.08%	Shs Float	15.35M	Perf Month	8.72%
Income	-285.67M	PEG	-	EPS next Q	-0.81	Inst Own	27.16%	Short Float	10.75%	Perf Quarter	-36.62%
Sales	2.32M	P/S	96.97	EPS this Y	88.07%	Inst Trans	-16.77%	Short Ratio	10.21	Perf Half Y	-40.27%
Book/sh	13.24	P/B	0.74	EPS next Y	22.60%	ROA	-103.26%	Short Interest	1.65M	Perf Year	-45.40%
Cash/sh	1.07	P/C	9.18	EPS next 5Y	-	ROE	-203.41%	52W Range	7.41 - 23.18	Perf YTD	-49.85%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.61%	ROI	-61.04%	52W High	-57.51%	Beta	1.91
Dividend TTM	-	Quick Ratio	1.23	Sales past 5Y	837.06%	Gross Margin	-332.80%	52W Low	32.93%	ATR (14)	0.78
Dividend Ex-Date	-	Current Ratio	1.23	EPS Y/Y TTM	19.76%	Oper. Margin	-3597.16%	RSI (14)	48.64	Volatility	6.45% 8.68%
Employees	-	Debt/Eq	0.71	Sales Y/Y TTM	1289.22%	Profit Margin	-12313.28%	Recom	1.67	Target Price	22.00
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	89.71%	Payout	-	Rel Volume	0.38	Prev Close	9.97
Sales Surprise	36.25%	EPS Surprise	-10.89%	Sales Q/Q	1197.62%	Earnings	May 09 AMC	Avg Volume	161.67K	Price	9.85
SMA20	5.91%	SMA50	-14.15%	SMA200	-36.02%	Trades		Volume	61,312	Change	-1.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-24	Resumed	Canaccord Genuity	Buy	$22
Oct-09-23	Initiated	H.C. Wainwright	Buy	$25
Jul-19-23	Resumed	Canaccord Genuity	Buy	$30

Jun-26-24 08:30AM	Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits (GlobeNewswire)
Jun-17-24 07:00AM	Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development (GlobeNewswire)
Jun-12-24 08:00AM	Cibus Announces $13.0 Million Registered Direct Offering (GlobeNewswire)
Jun-05-24 07:00AM	Cibus to Participate in Upcoming June Investor Events (GlobeNewswire)
May-30-24 07:00AM	Cibus' White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola (GlobeNewswire)
07:00AM	Loading…
May-15-24 07:00AM	Canada Added to a Growing List of Countries Regulating Cibus' Gene Editing Technologies Similar to Conventional Breeding (GlobeNewswire)
May-13-24 07:00AM	Cibus to Participate in the BMO Global Farm to Market Conference (GlobeNewswire) +5.69%
May-09-24 10:55PM	CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Cibus Reports First Quarter Financial Results and Provides Business Update (GlobeNewswire)
Apr-25-24 07:00AM	Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call (GlobeNewswire)
Mar-25-24 03:16PM	Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised) (Zacks) +5.25%
Mar-22-24 01:03PM	Cibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.10%
Mar-21-24 08:52PM	CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -9.01%
04:05PM	Cibus Reports Fourth Quarter Financial Results and Provides Business Update (GlobeNewswire)
Mar-19-24 08:30AM	Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (GlobeNewswire) -6.80%
08:26AM	Loading…
Mar-18-24 08:26AM	Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last? (Zacks) +5.13%
Mar-13-24 07:35AM	Cibus to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Mar-07-24 07:00AM	Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call (GlobeNewswire)
Feb-26-24 07:00AM	Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US (GlobeNewswire)
Feb-07-24 12:51PM	European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-25-24 04:30PM	European Parliaments Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques (GlobeNewswire)
Jan-17-24 07:00AM	Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales (GlobeNewswire)
Jan-09-24 07:00AM	Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells (GlobeNewswire) +6.27%
Jan-04-24 07:30AM	Cibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control system (GlobeNewswire)
Dec-12-23 07:30AM	Cibus Announces $20.3 Million Registered Direct Offering (GlobeNewswire)
Dec-01-23 08:00AM	European Union Notifies Trading Partners on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +10.34%
Nov-30-23 08:00AM	Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus (GlobeNewswire)
Nov-09-23 04:05PM	Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +19.76%
Nov-06-23 08:00AM	European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire)
Nov-02-23 04:05PM	Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call (GlobeNewswire)
09:33AM	Loading…
Oct-09-23 09:33AM	Oracle upgraded, Spotify downgraded: Wall Street's top analyst calls (The Fly) -8.67%
Sep-18-23 05:23PM	Jim Collins to Join Cibus Board of Directors (GlobeNewswire) +15.85%
Sep-05-23 08:00AM	Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) +11.27%
Aug-09-23 05:00PM	Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.76%
Aug-03-23 12:30PM	Steve Berreth Appointed as General Counsel and Corporate Secretary (GlobeNewswire) +5.33%
07:00AM	Cibus to Report Second Quarter 2023 Financial Results on August 10, 2023 and Host Conference Call (GlobeNewswire)
Aug-02-23 04:05PM	Cibus to Present at the Canaccord 43rd Annual Growth Conference (GlobeNewswire)
Jul-12-23 08:30AM	Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production (GlobeNewswire)
Jul-05-23 04:05PM	Cibus Welcomes European Commission Proposal on Regulation of Plants Obtained from New Genomic Techniques (GlobeNewswire) +26.93% +22.32%
Jun-15-23 08:45AM	Cibus Applauds the Genetic Technology (Precision Breeding) Act 2023 Passed in the United Kingdom (GlobeNewswire) +10.78%
07:00AM	Cibus to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-07-23 07:00AM	Cibus White Mold Resistance Trait in Canola Achieves Another Important Milestone (GlobeNewswire)
Jun-01-23 07:00AM	Cibus Announces Closing of Merger with Calyxt to Create Industry Leading Precision Gene Editing and Trait Development Company (GlobeNewswire) -17.30%

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2010 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gocal Gregory Francis William	Chief Scientific Officer & EVP	Jul 15 '24	Sale	10.01	2,000	20,023	314,844	Jul 17 04:10 PM
Gocal Gregory Francis William	Chief Scientific Officer & EVP	Jul 12 '24	Sale	10.00	2,000	20,000	316,844	Jul 15 05:07 PM
Gocal Gregory Francis William	Chief Scientific Officer & EVP	Jun 27 '24	Sale	10.00	2,000	20,000	318,844	Jul 15 05:03 PM
RIGGS RORY B	Chief Executive Officer	Dec 12 '23	Buy	10.58	517,107	5,470,992	1,622,495	Dec 14 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBUS

Cibus Inc

Upgrade your FINVIZ experience